Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment

scientific article published in January 1999

Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0196-0644(99)70411-7
P698PubMed publication ID9867881

P2093author name stringR E O'Connor
P McGraw
L Edelsohn
P2860cites workTissue plasminogen activator for acute ischemic strokeQ29619377
Factors associated with early presentation of acute strokeQ39404424
Rapid response to stroke symptoms: the Delay in Accessing Stroke Healthcare (DASH) studyQ40871880
Denial of illness in strokeQ40904481
Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study GroupQ41012889
Urgent therapy for acute stroke. Effects of a stroke trial on untreated patientsQ41012896
Emergency identification and treatment of acute ischemic strokeQ41635189
An analysis of time of presentation after strokeQ42075939
Recombinant tissue plasminogen activator in acute thrombotic and embolic strokeQ43606519
When is thrombolysis justified in patients with acute ischemic stroke? A bioethical perspectiveQ48821583
Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study GroupQ48913792
Thrombolytic therapy with streptokinase in acute ischemic strokeQ48962264
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)Q55063586
Delay in the prehospital phase of acute myocardial infarction. Lack of influence on incidence of sudden deathQ67460219
An illness behavior paradigm: a conceptual exploration of a situational-adaptation perspectiveQ70631787
Time of hospital presentation in patients with acute strokeQ71840161
Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST)Q72157135
Current emergency department management of stroke in Houston, TexasQ72622135
A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke StQ73592931
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectthrombolysisQ1931577
P304page(s)9-14
P577publication date1999-01-01
P1433published inAnnals of Emergency MedicineQ4767847
P1476titleThrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment
P478volume33

Reverse relations

cites work (P2860)
Q53871409Are outpatient admission sources truly a risk factor for appendiceal rupture?
Q34293439Candidates for thrombolytic treatment in acute ischaemic stroke--where are our patients in Hong Kong?
Q36059382Current management of acute ischemic stroke. Part 1: Thrombolytics and the 3-hour window
Q36344095Diagnostic imaging for acute ischemic stroke management
Q34803923Disparities in accessibility of certified primary stroke centers
Q33378619Disparities in knowledge of heart attack and stroke symptoms among adult men: an analysis of behavioral risk factor surveillance survey data.
Q36871843EMS management of acute stroke--out-of-hospital treatment and stroke system development (resource document to NAEMSP position statement).
Q33704792Early Experience of Translating pH-Weighted MRI to Image Human Subjects at 3 Tesla
Q37201837Emergency medical services use by stroke patients: a population-based study
Q37167367Factors influencing nonadministration of thrombolytic therapy in early arrival strokes in a university hospital in Hyderabad, India
Q60669981Impacto de la activación del Código Ictus en la eficacia del tratamiento trombolítico
Q35752293Improving the efficiency of delivery of thrombolysis for acute stroke: a systematic review.
Q34262372Intravenous thrombolysis for acute ischemic stroke patients presenting with mild symptoms
Q90382888Knowledge and Poor Understanding Factors of Stroke and Heart Attack Symptoms
Q73832989Lack of t-PA use for acute ischemic stroke in a community hospital: high incidence of exclusion criteria
Q33922434MR perfusion imaging in acute ischemic stroke.
Q34313475Neuroprotection for ischaemic stroke: an unattainable goal?
Q35195649Optimization modeling to maximize population access to comprehensive stroke centers.
Q35660646Physiologic imaging in acute stroke: Patient selection.
Q24187522Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack
Q92967772Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack
Q80631000Prehospital triage to stroke centres: is it a solution to the problem?
Q40551912Racial and ethnic disparities in pediatric appendicitis rupture rate
Q28166505Stroke, dementia, and drug delivery
Q34492158Stroke: from recognition by the public to management by emergency medical services
Q46891457TPA use for stroke in the Registry of the Canadian Stroke Network.
Q88920978Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence
Q82603798Telestroke: extending stroke expertise into underserved areas

Search more.